Delivery Order SPE2DB20D3103-SPE2DB21FL9W5
- Not listed
- This federal contract award is for a prime vendor pharmaceutical supply contract held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,108.29, was awarded by the Defense Logistics Agency (DLA) and is for the delivery of a broad range of pharmaceutical products, medical supplies, and equipment to support military and veterans' healthcare programs. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 16, 2021. The...
- This federal contract award is for a prime vendor pharmaceutical distribution contract held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,517.76, was awarded by the Defense Logistics Agency (DLA) on November 20, 2020, with an ultimate completion date of November 23, 2020. The contract is for the delivery of a variety of pharmaceutical products, medical supplies, and equipment to support military treatment facilities, veterans' healthcare programs, and...
- This federal contract award is for a prime vendor pharmaceutical distribution contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $14,492.74 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) for pharmaceutical products and medical supplies to support military treatment facilities and veterans' healthcare programs. The contract has an ultimate completion date of July 22, 2021. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- This federal contract award is for a prime vendor pharmaceutical delivery order to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,428.92 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) on July 12, 2021, with a completion date of July 13, 2021. The contract is for the delivery of a variety of pharmaceutical products, including specialty medications, brand-name drugs, generic pharmaceuticals, and medical supplies to support military treatment...
- This federal contract award is for a prime vendor pharmaceutical distribution contract held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,523.32 delivery order was awarded by the Defense Logistics Agency (DLA) for pharmaceutical and medical supply products to support military healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,714.22 for pharmaceutical and medical supply distribution. The contract was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of December 3, 2020. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary...
- This federal contract award is for medical supplies and pharmaceutical products provided by Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, has a ceiling value of $81,236.49 and a period of performance through December 29, 2023. It is a firm fixed-price delivery order contract for a range of medical commodities, including specialty medications, generic drugs, brand-name...
- This federal contract award was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,428.67, is for pharmaceutical and medical supply products to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $2,334.85, is for the delivery of pharmaceutical products and medical supplies to support military treatment programs and facilities. The contract is a firm fixed price delivery order and does not utilize any set-aside designations. Amerisourcebergen Drug Corp holds an Indefinite Delivery...
- This federal contract award is for a prime vendor pharmaceutical contract held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This Indefinite Delivery Contract (IDC) enables Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB21FL9W5Delivery Order
This federal contract award is for a prime vendor pharmaceutical contract held by Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, awarded by the Defense Logistics Agency (DLA), is a delivery order valued at $3,338.48 for pharmaceutical products and medical supplies to support military and veteran healthcare programs. The contract has an ultimate completion date of December 31, 2020 and is a firm fixed price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical and medical products to DLA facilities globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 12/30/20 |